在社交媒体中评估PCSK9抑制剂的视频内容质量
David Gabriel David-Pardo1, Julián E Barahona-Correa2, Nancy M Herrera-Leaño1
1School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia; Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia; Division of Cardiology, Hospital Universitario San Ignacio, Bogotá, Colombia.
概括
关于PCSK9抑制剂 (PCSK9i) 的YouTube®视频显示出比Facebook®内容更高的参与度和可靠性. 营利性组织创建最全面和值得信赖的PCSK9i视频,尽管整体质量需要改进.
科学领域:
- 心血管医学 心血管医学
- 数字健康沟通数字健康沟通
- 健康信息的传播和传播.
背景情况:
- 互联网是健康信息的主要来源,患者经常使用YouTube®和Facebook®等社交媒体平台.
- 在线健康内容的可靠性,特别是关于治疗失脂症的治疗方法,如PCSK9抑制剂 (PCSK9i),在很大程度上是未知的.
- 评估社交媒体上的健康信息质量对于患者教育和明智决策至关重要.
研究的目的:
- 评估讨论PCSK9抑制剂的YouTube®和Facebook®视频的特征,用户参与度,可靠性,全面性和质量.
- 为了比较不同平台 (YouTube®与Facebook®) 和语言 (英语与西班牙语) 的视频内容.
- 确定影响PCSK9抑制剂在线健康信息质量和可靠性的因素.
主要方法:
- 一项分析观察性研究涉及对来自YouTube®和Facebook®的203个PCSK9抑制剂视频进行分析.
- 使用了经过验证的工具,包括修改的DISCERN (mDISCERN) 以确保可靠性,修改的内容评分以确保全面性,以及全球质量评分 (GQS) 以确保整体质量.
- 基于平台,来源和语言的视频指标进行比较,具有优异的评分间可靠性 (kappa > 0.89).
主要成果:
- 与Facebook®视频相比,YouTube®视频的平均浏览量,持续时间和用户参与度明显更高.
- 在Facebook®视频中,非有价值内容的比例更高 (19.6%对3.2%).
- YouTube® 视频,特别是来自营利性组织的视频,在可靠性,全面性和质量方面通常获得更高的评分.
结论:
- 与Facebook®相比,YouTube®是PCSK9抑制剂信息的更具吸引力和可靠的平台.
- 营利性组织正在在线制作最可靠和最全面的PCSK9抑制剂内容.
- 尽管取得了改进,但在线PCSK9抑制剂信息的整体质量仍不理想,需要加强监督和准确传播策略.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
884
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
884
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Antihypertensive Drugs: Direct Renin Inhibitors
845
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
845
Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
905
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
905


